Previous Close | 7.28 |
Open | 7.15 |
Bid | 6.39 x 1100 |
Ask | 7.32 x 1100 |
Day's Range | 7.07 - 7.33 |
52 Week Range | 4.50 - 8.77 |
Volume | |
Avg. Volume | 60,777 |
Market Cap | 328.123M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 24.08 |
Subscribe to Yahoo Finance Plus to view Fair Value for INCR
Thank you for standing by, and welcome to the InterCure first quarter 2022 earnings call and webcast. A copy of the company's earnings press release is available on the News and Events section of our website at www.intercure.co. With me on today's call are Alex Rabinovich, InterCure's chief executive officer, and Amos Cohen, the company's chief financial officer.
Quarterly revenues Quarterly revenues Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million for the Q1 of 2022 compared to $2 million in Q1 of 2021 Seventh consecutive quarter of positive cash flow from operations $91 million cash on March 31, 2022 Revenue growth expected to continue in the second quarter and throughout 2022 NEW YORK and TORONTO and HERZLIYA, Israel , May 16, 2022 (GLOBE NEWSWIRE)
Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ETNEW YORK and TORONTO and HERZLIYA, Israel, May 16, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the first quarter of 2022 after market close on Monday, May 16, 2022. The Company will conduct a conference call on Tuesday, May 17, 2022, at 8:00a.m. (Eastern Time) to review the results as well